{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:59:13Z","timestamp":1791248353500,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.bone.2004.07.004","type":"journal-article","created":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T11:17:41Z","timestamp":1096543061000},"page":"1200-1207","source":"Crossref","is-referenced-by-count":103,"title":["TNF-\u03b1 antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis"],"prefix":"10.1016","volume":"35","author":[{"given":"N.","family":"Saidenberg-Kermanac'h","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lemeiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"deVernejoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Cohen-Solal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2004.07.004_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0953-6205(02)00129-2","article-title":"Peripheral bone density in patients with rheumatoid arthritis and factors which influence it","volume":"13","author":"Kelly","year":"2002","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.bone.2004.07.004_bib2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.61.11.1007","article-title":"Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis","volume":"61","author":"Harrison","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2004.07.004_bib3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.51.6.826","article-title":"Bone mass in patients with rheumatoid arthritis","volume":"51","author":"Laan","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2004.07.004_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2004.07.004_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM200003163421110","article-title":"Tumor necrosis factor blockers in rheumatoid arthritis","volume":"342","author":"Pisetsky","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2004.07.004_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/rheumatology\/35.3.213","article-title":"Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium","volume":"35","author":"Fujikawa","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.bone.2004.07.004_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/bbrc.1997.7404","article-title":"A new mechanism of bone destruction in rheumatoid arthritis; synovial fibroblasts induce osteoclastogenesis","volume":"240","author":"Takayanagi","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2004.07.004_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/ard.55.11.816","article-title":"Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis","volume":"55","author":"Fujikawa","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2004.07.004_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor \u03baB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2004.07.004_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T cells support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2004.07.004_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bone.2004.07.004_bib12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#","article-title":"Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients","volume":"44","author":"Kotake","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2004.07.004_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells","volume":"25","author":"Hofbauer","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.07.004_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2004.07.004_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/bbrc.1998.9294","article-title":"Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the action of stromal cells with the osteoclast","volume":"250","author":"Akatsu","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2004.07.004_bib16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1359\/jbmr.1999.14.9.1478","article-title":"A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1\u03b2, TNF-\u03b1, PTH, PTHrp, and 1,25 [oh]2D3","volume":"14","author":"Morony","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.07.004_bib17","first-page":"144","article-title":"Osteoprotegerin and inflammation","volume":"13","author":"Saidenberg Kermanac'h","year":"2002","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bone.2004.07.004_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1297-319X(03)00131-3","article-title":"Osteoprotegerin, inflammation and rheumatoid arthritis","volume":"71","author":"Saidenberg Kermanac'h","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bone.2004.07.004_bib19","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/art.11150","article-title":"Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice","volume":"48","author":"Schett","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2004.07.004_bib20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2004.07.004_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1023\/B:JOCI.0000029116.12371.bf","article-title":"Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis","volume":"24","author":"Saidenberg-Kermanac'h","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bone.2004.07.004_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2004.07.004_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2003.009563","article-title":"Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 weeks, phase II study","volume":"62","author":"van de Putte","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2004.07.004_bib24","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2004.07.004_bib25","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/sj.gt.3300785","article-title":"Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor","volume":"5","author":"Mageed","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.bone.2004.07.004_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.1997.12.6.935","article-title":"The functional block of TNF but not IL-6 prevents bone loss in ovariectomized mice","volume":"12","author":"Kimble","year":"1997","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2004.07.004_bib27","first-page":"S185","article-title":"Infliximab in spondylarthropathy influence on bone density","volume":"20","author":"Demis","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bone.2004.07.004_bib28","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/283666a0","article-title":"Immunisation against heterologous type II collagen induces arthritis in mice","volume":"283","author":"Courtenay","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.bone.2004.07.004_bib29","first-page":"26","article-title":"Experimental arthritis in non human primates. Induction by bovine type II collagen","volume":"54","author":"Cathcart","year":"1986","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bone.2004.07.004_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ard.46.9.691","article-title":"Experimental autoimmune arthritis in mice. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis","volume":"46","author":"Boissier","year":"1987","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2004.07.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780330101","article-title":"Arthritogenicity of minor cartilage collagens (type IX and type XI) in mice","volume":"33","author":"Boissier","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2004.07.004_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","article-title":"Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo","volume":"157","author":"Lacey","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2004.07.004_bib33","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1073\/pnas.89.20.9784","article-title":"Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis","volume":"89","author":"William","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2004.07.004_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1359\/jbmr.040119","article-title":"In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass","volume":"19","author":"Geoffroy","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.07.004_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.07.004_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(00)00406-3","article-title":"Bone mass changes of tibial and vertebral bones in young and adult rats with collagen-induced arthritis","volume":"28","author":"Enokida","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.07.004_bib37","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/en.141.11.3956","article-title":"Inhibition of osteoblast differentiation by tumor necrosis factor-alpha","volume":"141","author":"Gilbert","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2004.07.004_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1043-4666(03)00106-6","article-title":"Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor","volume":"22","author":"Abbas","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2004.07.004_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","article-title":"Tumor necrosis factor-\u03b1: molecular and cellular mechanisms in skeletal pathology","volume":"321","author":"Nanes","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.bone.2004.07.004_bib40","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","article-title":"Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis","volume":"161","author":"Romas","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2004.07.004_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/art.11487","article-title":"Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction","volume":"50","author":"Zwerina","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2004.07.004_bib42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9440(10)63144-6","article-title":"Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis","volume":"164","author":"Redlich","year":"2004","journal-title":"Am. J. Pathol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204002996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204002996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T04:51:08Z","timestamp":1549169468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328204002996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S8756328204002996"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2004.07.004","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}